stockportfolio.pro
Vir Biotechnology, Inc. Gross Profit 2017–2025
Vir Biotechnology, Inc. (VIR) annual gross profit by fiscal year, computed from SEC filings. Compound growth -28.7%/yr over 8 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $68.53M | 100.0% | -6.6% |
| FY 2024 | $73.36M | 98.9% | -12.1% |
| FY 2023 | $83.42M | 96.8% | -94.3% |
| FY 2022 | $1.47B | 90.9% | +42.7% |
| FY 2021 | $1.03B | 94.0% | — |
| FY 2020 | — | — | — |
| FY 2019 | — | — | — |
| FY 2018 | — | — | — |
| FY 2017 | — | — | — |
Source: Vir Biotechnology, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Vir Biotechnology, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeVir Biotechnology, Inc. — frequently asked questions
What is Vir Biotechnology, Inc.'s gross profit?
Vir Biotechnology, Inc. (VIR) reported gross profit of $68.53M for fiscal year 2025, per its SEC filings.
How has Vir Biotechnology, Inc.'s gross profit changed over time?
Between fiscal 2017 and 2025, VIR's gross profit declined at roughly 28.7% per year (compound annual rate), from $1.03B to $68.53M.
Where does this data come from?
Figures are computed from Vir Biotechnology, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.